NO20071152L - Lysinbaserte forbindelser - Google Patents

Lysinbaserte forbindelser

Info

Publication number
NO20071152L
NO20071152L NO20071152A NO20071152A NO20071152L NO 20071152 L NO20071152 L NO 20071152L NO 20071152 A NO20071152 A NO 20071152A NO 20071152 A NO20071152 A NO 20071152A NO 20071152 L NO20071152 L NO 20071152L
Authority
NO
Norway
Prior art keywords
lysine
based compounds
cycloalkyl
alkyl
nao
Prior art date
Application number
NO20071152A
Other languages
English (en)
Norwegian (no)
Inventor
Brent Richard Stranix
Valerie Perron
Original Assignee
Ambrilia Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambrilia Biopharma Inc filed Critical Ambrilia Biopharma Inc
Publication of NO20071152L publication Critical patent/NO20071152L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/41—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20071152A 2004-08-02 2007-03-01 Lysinbaserte forbindelser NO20071152L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2004/001440 WO2006012725A1 (en) 2004-08-02 2004-08-02 Lysine based compounds

Publications (1)

Publication Number Publication Date
NO20071152L true NO20071152L (no) 2007-03-01

Family

ID=35786842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071152A NO20071152L (no) 2004-08-02 2007-03-01 Lysinbaserte forbindelser

Country Status (14)

Country Link
EP (2) EP2165709B1 (de)
JP (1) JP4579970B2 (de)
CN (1) CN1942436B (de)
AT (1) ATE417823T1 (de)
AU (2) AU2004322123B2 (de)
BR (1) BRPI0418651A (de)
CA (1) CA2560071C (de)
DE (1) DE602004018548D1 (de)
ES (2) ES2319996T3 (de)
IL (1) IL180958A0 (de)
MX (1) MX2007001278A (de)
NO (1) NO20071152L (de)
RU (1) RU2009139259A (de)
WO (1) WO2006012725A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
EP2165709B1 (de) 2004-08-02 2016-03-16 Ambrilia Biopharma Inc. Pharmazeutische Zusammensetzungen enthaltend eine Lysin-basierende Verbindung und ein HIV-antivirales order antiretrovirales Agens
WO2007062526A1 (en) 2005-11-30 2007-06-07 Ambrilia Biopharma Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
AU2007287353A1 (en) * 2006-07-17 2008-02-28 Ambrilia Biopharma Inc. Method for improving pharmacokinetics
ES2628730T3 (es) 2006-09-21 2017-08-03 Taimed Biologics, Inc. Inhibidores de proteasa
WO2009148600A2 (en) * 2008-06-06 2009-12-10 Concert Pharmaceuticals, Inc. Deuterated lysine-based compounds
CA2762582A1 (en) 2009-05-27 2010-12-02 Merck Sharp & Dohme Corp. Hiv protease inhibitors
US9079834B2 (en) 2010-10-28 2015-07-14 Merck Canada Inc. HIV protease inhibitors
US9187415B2 (en) 2010-10-29 2015-11-17 Merck Canada Inc. Sulfonamides as HIV protease inhibitors
US9133157B2 (en) 2011-10-26 2015-09-15 Merck Canada Inc. HIV protease inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
WO2001076531A2 (en) * 2000-04-07 2001-10-18 University Of Maryland, Baltimore Bile acid containing prodrugs with enhanced bioavailability
US6617310B2 (en) * 2000-07-19 2003-09-09 Bristol-Myers Squibb Pharma Company Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
CA2418479C (en) * 2000-08-18 2007-12-18 The Board Of Trustees Of The University Of Illinois Prodrugs of betulinic acid derivatives for the treatment of cancer
US6506786B2 (en) * 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
US6632816B1 (en) * 2002-12-23 2003-10-14 Pharmacor Inc. Aromatic derivatives as HIV aspartyl protease inhibitors
EP2165709B1 (de) 2004-08-02 2016-03-16 Ambrilia Biopharma Inc. Pharmazeutische Zusammensetzungen enthaltend eine Lysin-basierende Verbindung und ein HIV-antivirales order antiretrovirales Agens

Also Published As

Publication number Publication date
DE602004018548D1 (de) 2009-01-29
RU2009139259A (ru) 2011-04-27
EP2165709A2 (de) 2010-03-24
EP2165709B1 (de) 2016-03-16
HK1105406A1 (en) 2008-02-15
AU2009230800A1 (en) 2009-11-19
JP2007525527A (ja) 2007-09-06
CN1942436A (zh) 2007-04-04
CA2560071A1 (en) 2006-02-09
EP1773763B1 (de) 2008-12-17
ATE417823T1 (de) 2009-01-15
MX2007001278A (es) 2007-09-14
EP1773763A1 (de) 2007-04-18
ES2319996T3 (es) 2009-05-18
AU2004322123B2 (en) 2009-08-13
ES2575871T3 (es) 2016-07-01
AU2004322123A1 (en) 2006-02-09
JP4579970B2 (ja) 2010-11-10
BRPI0418651A (pt) 2007-05-29
CN1942436B (zh) 2011-03-23
EP2165709A3 (de) 2010-06-23
EP1773763A4 (de) 2007-08-08
IL180958A0 (en) 2007-07-04
CA2560071C (en) 2012-09-25
WO2006012725A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
IL180958A0 (en) Lysine based compounds
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
AR057914A1 (es) Compuestos organicos de azufre y su uso
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
SE0300956L (sv) Stabilisatorblandningar
EP1795536A4 (de) Phosphoramiditverbindung und verfahren zur herstellung von oligo-rna
ATE425983T1 (de) Siloxy substituierte metallocenkatalysatoren
BR0211844A (pt) Composto e ativador de receptor delta ativado por proliferador e peroxissoma
DK2036943T3 (da) Compositions containing fluorine substituted olefins
DE60237244D1 (de) Photostabile organische Sonnenschutzmittel mit antioxidativen Eigenschaften
NO20071476L (no) Antidiuretiske midler.
DE60228990D1 (de) Bicyclische verbindung
TW200600971A (en) Calixresorcinarene compounds, photoresist base materials, and compositions thereof
DK2000473T3 (da) Trehalose-forbindelse og lægemiddel omfattende forbindelsen
DE60223904D1 (de) Benzylaminanalogen
BR0117191A (pt) Composições nanoparticuladas de isotretinoina
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины
ATE444968T1 (de) Neuroprotektive verbindungen und deren verwendungen
DE60238116D1 (de) Halogenierte chinolinderivate und mittel zur bekämpfung von ectoparasiten
DE60208477D1 (de) Wasser- und Öl-abweisende Zusammensetzung und daraus gebildeter Formkörper
DE602006012361D1 (de) Schmutzlösungsmittel
BR0206922A (pt) Compostos orgânicos
PT1004241E (pt) Agentes insecticidas e acaricidas de 2-aril-delta 2-1,3,4-(oxa e tia) diazolina
DK0787710T3 (da) Fluorpropenforbindelse, et insekticid indeholdende samme og et mellemprodukt til fremstilling deraf
DK1072601T3 (da) 4-Arylpiperidinderivater til behandling af pruritus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application